BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 18975529)

  • 21. [The genetics of type 1 Charcot-Marie-Tooth disease, the hereditary focal neuropathies and the hereditary distal motor neuropathies].
    Sevilla T
    Rev Neurol; 2000 Jan 1-15; 30(1):71-9. PubMed ID: 10743001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Charcot-Marie-Tooth type X: A novel mutation in the Cx32 gene with central conduction slowing.
    Seeman P; Mazanec R; Ctvrtecková M; Smilková D
    Int J Mol Med; 2001 Oct; 8(4):461-8. PubMed ID: 11562788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Charcot-Marie-tooth disease.
    Casasnovas C; Cano LM; Albertí A; Céspedes M; Rigo G
    Foot Ankle Spec; 2008 Dec; 1(6):350-4. PubMed ID: 19825739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular basis of Charcot-Marie-Tooth neuropathy].
    Hayasaka K
    Nihon Rinsho; 1996 Aug; 54(8):2243-51. PubMed ID: 8810804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capillary electrophoresis for the detection of PMP22 gene duplication: study in Mexican patients.
    Hernández-Zamora E; de la Luz Arenas-Sordo M; Maldonado-Rodríguez R
    Electrophoresis; 2008 Apr; 29(7):1582-4. PubMed ID: 18318003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).
    Sereda MW; Meyer zu Hörste G; Suter U; Uzma N; Nave KA
    Nat Med; 2003 Dec; 9(12):1533-7. PubMed ID: 14608378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis of the small heat shock protein 27 gene in chinese patients with Charcot-Marie-Tooth disease.
    Tang B; Liu X; Zhao G; Luo W; Xia K; Pan Q; Cai F; Hu Z; Zhang C; Chen B; Zhang F; Shen L; Zhang R; Jiang H
    Arch Neurol; 2005 Aug; 62(8):1201-7. PubMed ID: 16087758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Charcot-Marie-Tooth disease type 1A: a family study with microsatellites.
    Qu Y; Carpenter NJ; Whetsell L; Smith SP; Say B
    J Okla State Med Assoc; 1996 Nov; 89(11):395-9. PubMed ID: 8972170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease).
    Berger P; Niemann A; Suter U
    Glia; 2006 Sep; 54(4):243-57. PubMed ID: 16856148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic evaluation of inherited motor/sensory neuropathy.
    Chance PF
    Suppl Clin Neurophysiol; 2004; 57():228-42. PubMed ID: 16106622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1.
    Huehne K; Benes V; Thiel C; Kraus C; Kress W; Hoeltzenbein M; Ploner CJ; Kotzian J; Reis A; Rott HD; Rautenstrauss BW
    Hum Mutat; 2003 Jan; 21(1):100. PubMed ID: 12497641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Charcot-Marie-Tooth (CMT) disease 1A with superimposed inflammatory polyneuropathy in children.
    Desurkar A; Lin JP; Mills K; Al-Sarraj S; Jan W; Jungbluth H; Wraige E
    Neuropediatrics; 2009 Apr; 40(2):85-8. PubMed ID: 19809938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cochlear implantation in a patient with deafness induced by Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathies).
    Postelmans JT; Stokroos RJ
    J Laryngol Otol; 2006 Jun; 120(6):508-10. PubMed ID: 16772060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Strategies for clinical and molecular diagnosis of Charcot-Marie-Tooth 1A among Mexican patients].
    Hernández-Zamora E; Arenas-Sordo Mde L; Escobar-Cedillo RE; González-Huerta NC; Leyva-García N; Maldonado-Rodríguez R
    Gac Med Mex; 2007; 143(5):383-9. PubMed ID: 18246932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dominant Charcot-Marie-Tooth syndrome and cognate disorders.
    Pareyson D; Marchesi C; Salsano E
    Handb Clin Neurol; 2013; 115():817-45. PubMed ID: 23931817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.
    Passage E; Norreel JC; Noack-Fraissignes P; Sanguedolce V; Pizant J; Thirion X; Robaglia-Schlupp A; Pellissier JF; Fontés M
    Nat Med; 2004 Apr; 10(4):396-401. PubMed ID: 15034573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The p.R1109X mutation in SH3TC2 gene is predominant in Spanish Gypsies with Charcot-Marie-Tooth disease type 4.
    Claramunt R; Sevilla T; Lupo V; Cuesta A; Millán JM; Vílchez JJ; Palau F; Espinós C
    Clin Genet; 2007 Apr; 71(4):343-9. PubMed ID: 17470135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical phenotype of Charcot-Marie-Tooth disease (CMT) and familial amyloid polyneuropathy (FAP)].
    Sobue G
    Rinsho Shinkeigaku; 2003 Nov; 43(11):769-74. PubMed ID: 15152460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myelin protein zero gene mutations in Taiwanese patients with Charcot-Marie-Tooth disease type 1.
    Lee YC; Soong BW; Lin KP; Lee HY; Wu ZA; Kao KP
    J Neurol Sci; 2004 Apr; 219(1-2):95-100. PubMed ID: 15050444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations.
    Azzedine H; Ravisé N; Verny C; Gabrëels-Festen A; Lammens M; Grid D; Vallat JM; Durosier G; Senderek J; Nouioua S; Hamadouche T; Bouhouche A; Guilbot A; Stendel C; Ruberg M; Brice A; Birouk N; Dubourg O; Tazir M; LeGuern E
    Neurology; 2006 Aug; 67(4):602-6. PubMed ID: 16924012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.